Evolent Health
EVH
161 hedge funds and large institutions have $1.31B invested in Evolent Health in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 47 increasing their positions, 51 reducing their positions, and 22 closing their positions.
32% more capital invested
Capital invested by funds: $987M → $1.31B (+$319M)
32% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 22
4% more funds holding
Funds holding: 155 → 161 (+6)
1.65% more ownership
Funds ownership: 93.39% → 95.05% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 51
18% less call options, than puts
Call options by funds: $3.16M | Put options by funds: $3.85M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$16.2M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$12.9M |
| 3 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$5.66M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$4.6M |
| 5 |
BlackRock
New York
|
+$4.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$10.2M |
| 2 |
Millennium Management
New York
|
-$7.72M |
| 3 |
VCM
Voce Capital Management
San Francisco,
California
|
-$5.35M |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
-$2.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.57M |
EVH Hedge Fund Activity: Q4 2020 in Review
161 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q4 2020, worth a combined $1.31B — up 32% from $987M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new EVH positions and 22 closed out — a net gain of 7 holders — while 47 added to existing stakes and 51 trimmed.
The largest buyer was Granahan Investment Management, adding an estimated $16.2M. The largest seller was Pictet Asset Management (UK), exiting entirely with an estimated $10.2M sold.
- 161 institutional investors held Evolent Health (EVH) as of Q4 2020, up from 155 in Q3 2020.
- Funds reported $1.31B of Evolent Health stock for Q4 2020, up 32% quarter-over-quarter.
- 29 funds opened new Evolent Health positions in Q4 2020 and 22 closed out, a net change of +7 holders.
- The largest Evolent Health buyer in Q4 2020 was Granahan Investment Management, an estimated $16.2M added.
- The largest Evolent Health seller in Q4 2020 was Pictet Asset Management (UK), an estimated $10.2M sold.
Based on aggregated 13F filings for Q4 2020.